Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 651 - 700 out of 8,056

Document Document Title
WO2005100587A3
The invention provides yeast strains, and polypeptides encoded by genes of such yeast strains, that have enantiospecific 2,2-disubstituted epoxide hydrolase activity. The invention also features nucleic acid molecules encoding such polyp...  
WO/2006/018211A1
The present invention relates to a process for the production of isoprenoids, in particular Coenzyme Q-10 by microorganisms. More particularly, the present invention relates to a process for increased production of Coenzyme Q-10 by micro...  
WO/2006/019209A1
The invention relates to a method and apparatus for compensating the lens shading phenomenon in image sensor. The invention first stores an inputted compensation reference value, identifies a center pixel using digital image signals rece...  
WO2004015119A3
This invention relates to processes for the preparation of ansamitocins, in particular ansamitocins that can be converted to maytansinol.  
WO/2006/015811A2
The invention relates to a dihydrocoumarin that has been technically produced by the biotransformation of coumarin and to associated production variants that are carried out with the aid of isolated enzymes and/or microorganisms. Pure co...  
WO/2006/015727A2
The invention relates to a method for producing, in essence, enantiomer-pure 3-hydroxycarboxylic acids or esters of general formula (III) by reacting racemic oxetan-2-ones of general formula (I) with compounds R3-OH of general formula (I...  
WO2005047509A8
The present invention relates to Mycobacterium ulceran virulence plasmid, pMUM001 and particularly to a cluster of genes carried by this plasmid that encode polyketide synthases (PKSs) and polyketide-modifying enzymes necessary and suffi...  
WO/2006/010246A1
A gene encoding a littorine mutase/hydroxylase has been isolated and characterized. The gene is used in processes of altering alkaloid biosynthesis. Transgenic plants containing the gene have been produced and used for the production of ...  
WO/2006/012277A2
biocatalytic process for preparing enantiomerically enriched pramipexole and pramipexole precursors are disclosed.  
WO/2006/011156A1
A novel fermentation fed batch process for producing the immunosuppressant, Tacrolimus (FK-506), using the mutant microorganism Streptomyces sp. utilizing vegetative oil as sole source of carbon in production medium, is provided herewith.  
WO/2006/009518A1
There is provided a new strain, i.e. the alternaria alternata var. monosporus ST­026R CGMCC No.0899, and its use in the production of paclitaxel. The invention also provides a method for the production of paclitaxel by using the strain ...  
WO/2006/009276A1
A polypeptide participating in the biosynthesis of pladienolide as a macrolide compound; a DNA coding for such a polypeptide; a variant thereof; a transformant in which part or the whole of such a DNA or variant thereof has been incorpor...  
WO2004035010A3  
WO/2006/010117A2
Methods and compositions are provided for production of flavonoids in microbial hosts. The compositions comprises a set of genes which encode for enzymes involved in one or more steps in the biosynthetic pathway for the conversion of phe...  
WO2005020883A3
A process of the large-scale fermentation of a highly productive ansamitocin-producing strains. A method for isolating crude ansamitocins. A method for purifying ansamitocins.  
WO/2005/123933A1
A process for preparing the compound of formula (II) by reacting the compound of formula (I) with an enzyme that can hydrolyze the ester bond: formula (I) and (II) where * indicates a chiral center, R1 and R2 each independently represent...  
WO/2005/121327A2
A polyketide synthase complex composed of polyketide synthase with 15 total modules, a non-ribosomal peptide synthetase with I module, and a cytochrome P450 hydroxylase is described. Also provided are novel Streptomyces species and metho...  
WO/2005/118777A3
The invention relates to a novel strain Saccharothrix actinomycete SA 103 deposited at CNCM on 16th February 2004, number I-3160 or a mutant strain thereof; a method and a medium for selection of said strain; and a method for the product...  
WO/2005/118777A2
The invention relates to a novel strain Saccharothrix actinomycete SA 103 deposited at CNCM on 16th February 2004, number I-3160 or a mutant strain thereof; a method and a medium for selection of said strain; and a method for the product...  
WO/2005/116061A2
The invention relates to DNA sequences coding for polypeptides which, in turn, participate in the enzymatic biosynthesis of polyketide compounds, and to amino acid sequences of said polypeptides. The invention also relates to the use of ...  
WO/2005/116200A2
The present invention provides polypeptides involved in cryptophycin biosynthesis and the nucleic acid molecules that encode such polypeptides. The nucleic acid molecules and polypeptides of the invention or variants thereof can be used ...  
WO2005080549A3
The invention relates to the use of trioxacarcins as agents for treating infections caused by fungi, parasites, viruses or bacteria. The invention also relates to the novel trioxacarcin derivatives as such, to drugs containing them or th...  
WO/2005/116200A3
The present invention provides polypeptides involved in cryptophycin biosynthesis and the nucleic acid molecules that encode such polypeptides. The nucleic acid molecules and polypeptides of the invention or variants thereof can be used ...  
WO/2005/112951A1
It is intended to provide an antitumor agent, which has established a strengthened function selectivity of acting exclusively on caner cells, lessened side effects, mastery of drug tolerance and so on, and has an activity of inducing cel...  
WO/2005/111214A1
The present invention relates to an ethanol producing microbial strain, such as Saccharomyces cerevisiae strain, being able to grow and produce ethanol from lignocellulosic hydrolysates comprising growth inhibiting compounds of the group...  
WO2005042756A3
Methods and compositions that can be used to make monatin or salt thereof from glucose, tryptophan, indole-3-lactic acid, indole-3-pyruvate, and 2-hydroxy 2-(indol-3-ylmethyl)-4-keto glutaric acid, are provided. Methods are also disclose...  
WO/2005/108590A2
The invention relates to a method for producing the optically active alkanols of formula (I), wherein n is an integer of from 0 to 5; Cyc represents an optionally substituted, mononuclear or polynuclear, saturated or unsaturated, carbocy...  
WO/2005/108594A1
An enzymatic ammonolysis process is provided for the preparation of intermediates used in preparing dipeptidyl peptidase IV inhibitors wherein the enzyme Candida antarctica lipase-B is used to catalyze the ammonolysis process.  
WO/2005/104871A1
A composition comprising statin wherein the composition is a flour comprising less than 10 wt.% of fat and the use of the composition comprising statin in the preparation a food product is disclosed. The process for the preparation of th...  
WO/2005/106006A3
Disclosed herein is a process for producing 6-hydroxynicotinic acid via biotransformation, the process comprises hydroxylation of nicotinic acid in aqueous medium using a novel microbial strain, Yersinia pseudotuberculosis MTCC 5129 cell...  
WO/2005/106006A2
Disclosed herein is a process for producing 6-hydroxynicotinic acid via biotransformation, the process comprises hydroxylation of nicotinic acid in aqueous medium using a novel microbial strain, Yersinia pseudotuberculosis MTCC 5129 cell...  
WO/2005/105811A1
A method for the regiospecific synthesis of rapamycin 42-ester derivatives is described. The method involves lipase-catalyzed acylation of 42 hydroxy rapamycin with an acyl donor such as a vinyl ester, an isopropenyl ester or an anhydrid...  
WO/2005/106011A2
A process for production of cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV is provided which employs a BOC-protected amine of the structure (3) prepared by subjecting an acid of the structure (1) to reduce amin...  
WO/2005/106007A1
A method for rapamycin-specific labeling using rapI, rapM and/or rapQ enzymes is described. Also are methods for generating crude enzyme extracts useful in the method of the invention. Uses of the specifically labeled rapamycin as diagno...  
WO/2005/105812A1
Methods for the synthesis of regiospecific rapamycin 42-hemiesters and regiospecific FK506 32-esters with dicarboxylic acids is described. The methods involve catalyzing the reaction between a rapamycin or a FK-506 and a dicarboxylic anh...  
WO2005054266A3
14-membered macrolide compounds such as erythromycins are provided with functional groups at the 14- and/or 15-position by providing a 14-membered aglycone template and feeding it to a strain capable of hydroxylating it at the 14 and/or ...  
WO/2005/104864A1
Edible oil comprising statin comprising at least 90% of di- and/or triglycerides having a saturated fatty acid (SAFA) content of less than 25 wt%, preferably containing at least 4 mg/g statin. Process for the preparation of an edible oil...  
WO2005021586A3
The invention provides a nucleic acid molecule comprising at least a functional fragment of the viomycin biosynthetic gene cluster, functional proteins encoded by the cluster, expression cassettes and recombinant host cells comprising a ...  
WO2005017159A3
The present invention discloses an isolated polynucleotide molecule derived from a polynucleotide encoding a polypeptide having L-sorbosone dehydrogenase activity comprising a partial nucleotide sequence of at least 20 consecutive nucleo...  
WO/2005/103280A1
A process for producing either a 3-benzamido-2-hydroxycarboxylic acid represented by 3-benzamido-2-hydroxy-3-phenylpropionic acid or a salt thereof. The process is safe and suitable for industrial production, and the target compound havi...  
WO2005073387A3
The invention relates to a method for obtaining the molybdopterin derivative precursor Z, whereby an over-production of precursor Z occurs in host organisms by recombinant expression of precursor Z synthesizing proteins. The invention fu...  
WO/2005/100587A2
The invention provides yeast strains, and polypeptides encoded by genes of such yeast strains, that have enantiospecific 2,2-disubstituted epoxide hydrolase activity. The invention also features nucleic acid molecules encoding such polyp...  
WO/2005/100582A3
The present invention relates to methods for converting plant cell wall polysaccharides into one or more products, comprising: treating the plant cell wall polysaccharides with an effective amount of a spent whole fermentation broth of a...  
WO/2005/100581A1
Novel isochroman compound pseudodeflectusin that is isolated from marine microbes parasitizing seaweeds and purified, having a chemical structure represented by the following formula (1) and that exhibits high growth inhibiting activity ...  
WO/2005/100582A2
The present invention relates to methods for converting plant cell wall polysaccharides into one or more products, comprising: treating the plant cell wall polysaccharides with an effective amount of a spent whole fermentation broth of a...  
WO/2005/100578A2
The invention provides yeast strains, and polypeptides encoded by genes of such yeast strains, that have enantiospecific meso-epoxide hydrolase activity. The invention also features nucleic acid molecules encoding such polypeptides, vect...  
WO/2005/100569A2
The invention provides yeast strains, and polypeptides encoded by genes of such yeast strains, that have enantiospecific styrene epoxide hydrolase activity. The invention also features nucleic acid molecules encoding such polypeptides, v...  
WO2005009391A3
Fermentation of a nutrient medium with a eubacterium Streptomyces sp. yields a novel antibacterial compound of structure (I).  
WO/2005/098011A1
The present invention discloses a new strain of Streptomyces sp. BICC 7522, its variants or mutants and use of the strain for the production of macrolides, process of production and purification of microlides.  
WO/2005/098012A1
An industrial process for producing hydroxyaldehydes efficiently, which solves the problems of conventional DERA, e.g., low stability to aldehydes, low catalytic activity for aldol condensation, and uncontrollableness in the number of co...  

Matches 651 - 700 out of 8,056